Long-term follow-up of the first randomized trial using neoadjuvant chemotherapy in stage Ib squamous carcinoma of the cervix: The final results
Long-term follow-up of the first randomized trial using neoadjuvant chemotherapy in stage Ib squamous carcinoma of the cervix: The final results
复制标题
DOI:
10.1006/gyno.1997.4812
复制
发表时间:
1997-10-01
影响因子:
4.7
通讯作者:
diPaola, G
中科院分区:
文献类型:
--
作者:
Sardi, JE;Giaroli, A;diPaola, G
Objective: To determine if three courses consisting of 50 mg/m(2) cis-platinum, 1 mg/m(2) vincristine, and 25 mg/m(2) bleomycin (day 1-3) at 10-day intervals can improve survival before Wertheim-Meigs + radiotherapy.Material: Two hundred five unselected stage Ib patients (having tumors >2 cm in diameter) were divided into two groups at random: (1) The group control consisted of 103 patients (56 bulky, >4 cm diameter) treated with Wertheim-Meigs (if the tumor was resectable with free surgical margins) + adjuvant radiotherapy to whole pelvis (extended field radiation was used only in patients with paraaortic lymph node metastases). When the tumor was unresectable, a surgical staging was performed and radiotherapy was the chosen treatment. (2) Neoadjuvant (102 patients, 61 bulky) had neoadjuvant chemotherapy and then the same treatment as the control patients.Results: After 67 (31-102) months of follow-up, no difference was seen in tumors >2 and 4 cm diameter) stage Ib patients. (C) 1997 Academic Press.